IL-6 receptor blockade impedes proinflammatory atypical Treg subset associated with immune checkpoint inhibitor-induced inflammatory arthritis Christopher.Koski@bruker.com IL-6 receptor blockade impedes proinflammatory atypical Treg subset associated with immune checkpoint inhibitor-induced inflammatory arthritis Read More »
Role of viral and host factors in determining the outcome of HBV-associated acute liver failure Christopher.Koski@bruker.com Role of viral and host factors in determining the outcome of HBV-associated acute liver failure Read More »
Immunotherapy for tuberculosis: emerging modalities, cross-disciplinary innovations, and roadmaps for drug-resistant disease Christopher.Koski@bruker.com Immunotherapy for tuberculosis: emerging modalities, cross-disciplinary innovations, and roadmaps for drug-resistant disease Read More »
Distinct NK cell dynamics in SARIFA positive colorectal cancer patients indicate persistent patient-intrinsic immune signatures after tumor resection Christopher.Koski@bruker.com Distinct NK cell dynamics in SARIFA positive colorectal cancer patients indicate persistent patient-intrinsic immune signatures after tumor resection Read More »
Single-cell multiomics reveals exosome-mediated reprogramming and clonotypic remodeling of T cells in triple-negative breast cancer Christopher.Koski@bruker.com Single-cell multiomics reveals exosome-mediated reprogramming and clonotypic remodeling of T cells in triple-negative breast cancer Read More »
Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma Christopher.Koski@bruker.com Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma Read More »
Pre-treatment polyfunctionality percentage (PFA) of CD8+ T cells is associated with development of immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICIs) Christopher.Koski@bruker.com Pre-treatment polyfunctionality percentage (PFA) of CD8+ T cells is associated with development of immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICIs) Read More »
New Insights into the Bioenergetic and Immunomodulatory Properties of Phospholipases A2 from Bothrops diporus Venom Christopher.Koski@bruker.com New Insights into the Bioenergetic and Immunomodulatory Properties of Phospholipases A2 from Bothrops diporus Venom Read More »
Integrative Analysis of Multi-omic Pathways Predict Cancer-Affected Lobes in Lung Cancer Christopher.Koski@bruker.com Integrative Analysis of Multi-omic Pathways Predict Cancer-Affected Lobes in Lung Cancer Read More »
LRRC15-CAR T cells for the treatment of osteosarcoma Christopher.Koski@bruker.com LRRC15-CAR T cells for the treatment of osteosarcoma Read More »
